SMTL ID : 4p5z.1

Human EphA3 Kinase domain in complex with quinoxaline derivatives

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x Q7M: 2-amino-1-[4-({[3-(trifluoromethyl)phenyl]carbamoyl}amino)phenyl]-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide(Non-covalent)

Q7M.1: 26 residues within 4Å: Chain A: V.41, G.42, A.43, G.44, V.49, A.65, K.67, E.84, I.87, M.88, F.91, I.96, I.97, T.113, E.114, Y.115, M.116, G.119, L.151, Y.156, H.158, L.167, V.176, S.177, D.178, F.179 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.49, A:A.65, A:K.67, A:E.84, A:I.87, A:D.178, A:F.179 Hydrogen bonds: A:E.84, A:E.84, A:E.114, A:M.116, A:M.116, A:D.178 Halogen bonds: A:V.176

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Unzue, A. et al., Pyrrolo[3,2-b]quinoxaline Derivatives as Types I1/2 and II Eph Tyrosine Kinase Inhibitors: Structure-Based Design, Synthesis, and in Vivo Validation. J.Med.Chem. (2014)

Release Date

2014-08-13

Peptides

Ephrin type-A receptor 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Ephrin type-A receptor 3

Related Entries With Identical Sequence